Bellevue Group’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-94,740
| Closed | -$4.22M | – | 161 |
|
|
2024
Q4 | $4.22M | Sell |
94,740
-102,974
| -52% | -$4.63M | 0.08% | 97 |
|
|
2024
Q3 | $8.62M | Sell |
197,714
-37,658
| -16% | -$1.42M | 0.14% | 88 |
|
|
2024
Q2 | $6.37M | Hold |
235,372
| – | – | 0.1% | 94 |
|
|
2024
Q1 | $6.88M | Buy |
235,372
+11,556
| +5% | +$350K | 0.1% | 91 |
|
|
2023
Q4 | $8.42M | Sell |
223,816
-15,463
| -6% | -$569K | 0.13% | 89 |
|
|
2023
Q3 | $10.8M | Sell |
239,279
-54,066
| -18% | -$3.28M | 0.17% | 89 |
|
|
2023
Q2 | $21.6M | Sell |
293,345
-170,022
| -37% | -$11.5M | 0.31% | 73 |
|
|
2023
Q1 | $27.2M | Sell |
463,367
-55,017
| -11% | -$3.03M | 0.39% | 68 |
|
|
2022
Q4 | $26.1M | Buy |
518,384
+104,100
| +25% | +$6.25M | 0.35% | 76 |
|
|
2022
Q3 | $36.1M | Sell |
414,284
-11,539
| -3% | -$1.21M | 0.52% | 58 |
|
|
2022
Q2 | $48.4M | Buy |
425,823
+63,491
| +18% | +$7.29M | 0.68% | 48 |
|
|
2022
Q1 | $46.9M | Hold |
362,332
| – | – | 0.54% | 59 |
|
|
2021
Q4 | $65.4M | Sell |
362,332
-31,251
| -8% | -$5.42M | 0.67% | 53 |
|
|
2021
Q3 | $58.4M | Hold |
393,583
| – | – | 0.59% | 55 |
|
|
2021
Q2 | $59.6M | Buy |
393,583
+65,664
| +20% | +$9.14M | 0.58% | 58 |
|
|
2021
Q1 | $42.6M | Buy |
327,919
+31,616
| +11% | +$4.05M | 0.45% | 72 |
|
|
2020
Q4 | $35.6M | Buy |
296,303
+17,882
| +6% | +$1.75M | 0.41% | 71 |
|
|
2020
Q3 | $20.8M | Buy |
278,421
+76,290
| +38% | +$5.29M | 0.29% | 87 |
|
|
2020
Q2 | $14.3M | Buy |
202,131
+5,995
| +3% | +$410K | 0.2% | 95 |
|
|
2020
Q1 | $12.9M | Sell |
196,136
-203
| -0.1% | -$16.2K | 0.25% | 73 |
|
|
2019
Q4 | $16M | Buy |
196,339
+24,693
| +14% | +$1.89M | 0.25% | 70 |
|
|
2019
Q3 | $12.4M | Buy |
171,646
+4,931
| +3% | +$362K | 0.23% | 77 |
|
|
2019
Q2 | $14.3M | Buy |
166,715
+22,876
| +16% | +$1.86M | 0.24% | 69 |
|
|
2019
Q1 | $11.6M | Buy |
143,839
+35,797
| +33% | +$2.68M | 0.64% | 49 |
|
|
2018
Q4 | $6.62M | Buy |
108,042
+3,392
| +3% | +$230K | 0.44% | 56 |
|
|
2018
Q3 | $7.52M | Buy |
104,650
+40,705
| +64% | +$2.56M | 0.48% | 59 |
|
|
2018
Q2 | $3.35M | Buy |
63,945
+43,945
| +220% | +$2.07M | 0.29% | 68 |
|
|
2018
Q1 | $868K | Hold |
20,000
| – | – | 0.09% | 111 |
|
|
2017
Q4 | $970K | Buy |
+20,000
| New | +$1.01M | 0.1% | 111 |
|
Other funds holding OMCL
CIP
Bellevue Group's OMCL Position: Q1 2025 in Review
Bellevue Group sold out of Omnicell (OMCL) in Q1 2025, closing a stake of 94,740 shares — an estimated $4.22M sold.
Bellevue Group first reported a position in OMCL in Q4 2017 and held it in 29 quarters. The position peaked at $65.4M in Q4 2021. 274 funds tracked by Wall St. Rank hold OMCL as of Q1 2025.
- Bellevue Group reported no remaining Omnicell position as of Q1 2025 after selling out during the quarter.
- Bellevue Group sold 94,740 Omnicell shares in Q1 2025, an estimated $4.22M.
- Bellevue Group first reported a position in Omnicell in Q4 2017 and held it in 29 quarters.
- Bellevue Group's Omnicell position peaked at $65.4M in Q4 2021.
- 274 funds tracked by Wall St. Rank held Omnicell as of Q1 2025.
Based on Bellevue Group's 13F filing for Q1 2025, filed 14 May 2025.